Ekso Bionics Holdings Stock In The News

EKSO Stock  USD 1.28  0.04  3.03%   
The tone or emotional content of news articles related to Ekso Bionics can affect its prices. Positive news sentiment can lead to an increase in demand for Ekso Bionics' stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Ekso Bionics' news coverage and content from conventional and social sources shows investors' bearish mood towards Ekso Bionics Holdings. The specific impact of Ekso Bionics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Ekso Bionics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Ekso Bionics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Ekso Bionics Backtesting and Ekso Bionics Hype Analysis.

Ekso Bionics Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Ekso Bionics to Participate at Centers f...
https://www.globenewswire.com/news-release/2023/11/16/2782242/29945/en/Ekso-Bionics-to-Participate-at-Centers-for-Medicare-Medicaid-Services-CMS-Second-Biannual-2023-Healthcare-Common-Procedure-Coding-System-HCPCS-Public-Meeting-on-Wednesday-November-.html
 Bullish
Macroaxis News: globenewswire.com
Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal
https://www.globenewswire.com/news-release/2023/11/02/2772774/29945/en/Centers-for-Medicare-Medicaid-Services-CMS-Codifies-Medicare-Coverage-for-Ekso-Indego-Personal.html
 Bullish
Macroaxis News: globenewswire.com
Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%
https://www.globenewswire.com/news-release/2023/10/26/2767972/29945/en/Ekso-Bionics-Reports-Third-Quarter-2023-Revenue-Growth-of-38.html
 Neutral
Macroaxis News: globenewswire.com
Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023
https://www.globenewswire.com/news-release/2023/10/19/2763666/29945/en/Ekso-Bionics-to-Report-Third-Quarter-2023-Financial-Results-on-October-26-2023.html
 Bullish
Macroaxis News: globenewswire.com
Ekso Bionics Supports Centers for Medica...
https://www.globenewswire.com/news-release/2023/09/27/2750321/29945/en/Ekso-Bionics-Supports-Centers-for-Medicare-Medicaid-Services-CMS-Proposed-Rule-to-Include-Personal-Exoskeletons-within-a-Medicare-Benefit-Category.html
 Bullish
Macroaxis News: globenewswire.com
Ekso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
https://www.globenewswire.com/news-release/2023/09/11/2740714/29945/en/Ekso-Bionics-to-Participate-at-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html
 Bullish
Macroaxis News: globenewswire.com
Ekso Bionics Reports Record Revenues of $4.7 Million in Second Quarter 2023
https://www.globenewswire.com/news-release/2023/07/27/2712685/29945/en/Ekso-Bionics-Reports-Record-Revenues-of-4-7-Million-in-Second-Quarter-2023.html
 Neutral
Macroaxis News: globenewswire.com
Ekso Bionics to Report Second Quarter 2023 Financial Results on July 27, 2023
https://www.globenewswire.com/news-release/2023/07/20/2708123/29945/en/Ekso-Bionics-to-Report-Second-Quarter-2023-Financial-Results-on-July-27-2023.html
 Bullish
Macroaxis News: globenewswire.com
Ekso Bionics Announces 61% Increase in First Quarter 2023 Revenues
https://www.globenewswire.com/news-release/2023/04/27/2656888/29945/en/Ekso-Bionics-Announces-61-Increase-in-First-Quarter-2023-Revenues.html
 Neutral
Macroaxis News: globenewswire.com
Ekso Bionics to Report First Quarter 2023 Financial Results on April 27, 2023
https://www.globenewswire.com/news-release/2023/04/20/2650917/29945/en/Ekso-Bionics-to-Report-First-Quarter-2023-Financial-Results-on-April-27-2023.html
 Bullish

Ekso Bionics Holdings Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Ekso and other traded companies coverage. We help investors stay connected with Ekso headlines for the 23rd of April to make an informed investment decision based on correlating the impacts of news items on Ekso Stock performance. Please note that trading solely based on the Ekso Bionics Holdings hype is not for everyone as timely availability and quick action are needed to avoid losses.
Ekso Bionics' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Ekso Bionics Holdings investors visualize upcoming and past events in order to time the market based on Ekso Bionics Holdings noise-free hype analysis.
Ekso Bionics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Ekso earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Ekso Bionics that are available to investors today. That information is available publicly through Ekso media outlets and privately through word of mouth or via Ekso internal channels. However, regardless of the origin, that massive amount of Ekso data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ekso Bionics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ekso Bionics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ekso Bionics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ekso Bionics alpha.

Ekso Largest EPS Surprises

Earnings surprises can significantly impact Ekso Bionics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-07-27
2023-06-30-0.28-0.31-0.0310 
2022-04-28
2022-03-31-0.41-0.360.0512 
2021-07-29
2021-06-30-0.25-0.190.0624 
2023-10-26
2023-09-30-0.31-0.240.0722 
2022-11-03
2022-09-30-0.24-0.33-0.0937 
2021-11-02
2021-09-30-0.25-0.150.140 
View All Earnings Estimates

Ekso Bionics Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Ekso Bionics Holdings Stock. Current markets are strongly bullish. About 76% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
16th of April 2024
Ekso Bionics Share Price Crosses Below 50 Day Moving Average of 1.65 - Defense World
at news.google.com 
benzinga news
12th of April 2024
Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Cent...
at benzinga.com 
benzinga news
5th of April 2024
Medical Robots Market is Expected to Reach 33.8 billion MarketsandMarkets
at benzinga.com 
Google News at Macroaxis
2nd of April 2024
Ekso Bionics Share Price Passes Below Fifty Day Moving Average of 1.81 - Defense World
at news.google.com 
Macroaxis News
28th of March 2024
Disposition of 12784 shares by Jerome Wong of Ekso Bionics at 0.9956 subject to Rule 16b-3
at MacroaxisInsider 
Google News at Macroaxis
22nd of March 2024
Acquisition by Jason Jones of 7474 shares of Ekso Bionics subject to Rule 16b-3
at news.google.com 
Google News at Macroaxis
14th of March 2024
Ekso Bionics director Lathan Corinna buys shares worth 15.5k By Investing.com - Investing....
at news.google.com 
sbwire news
5th of March 2024
EKSO Stock Earnings Ekso Bionics Holdings Misses EPS, Beats Revenue for Q4 2023
at investorplace.com 
Macroaxis News: globenewswire.com
4th of March 2024
Ekso Bionics Reports Record Annual Revenue of 18.3 Million
at globenewswire.com 
Google News at Macroaxis
25th of January 2024
- Analyzing Ekso Bionics Holdingss Short Interest By Benzinga - Investing.com UK
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ekso Bionics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ekso Bionics' short interest history, or implied volatility extrapolated from Ekso Bionics options trading.
When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock:
Check out Ekso Bionics Backtesting and Ekso Bionics Hype Analysis.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Ekso Stock analysis

When running Ekso Bionics' price analysis, check to measure Ekso Bionics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ekso Bionics is operating at the current time. Most of Ekso Bionics' value examination focuses on studying past and present price action to predict the probability of Ekso Bionics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ekso Bionics' price. Additionally, you may evaluate how the addition of Ekso Bionics to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Global Correlations
Find global opportunities by holding instruments from different markets
Is Ekso Bionics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.10)
Revenue Per Share
1.318
Quarterly Revenue Growth
0.365
Return On Assets
(0.27)
Return On Equity
(0.80)
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.